These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Clinical study of the effectiveness of bufexamac cream in superficial phlebitis and hypodermitis]. Ghislain E Brux Med; 1972 Jul; 52(7):517-21. PubMed ID: 4654171 [No Abstract] [Full Text] [Related]
30. Topical therapy for psoriasis. Lebwohl M; Abel E; Zanolli M; Koo J; Drake L Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153 [No Abstract] [Full Text] [Related]
31. Irrational use of skin-bleaching products can delay the diagnosis of leprosy. Mahé A; Ly F; Badiane C; Baldé Y; Dangou JM Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):119-21. PubMed ID: 12211896 [No Abstract] [Full Text] [Related]
32. Allergic reactions to wool fat alcohols. De Beukelaar L Dermatologica; 1968; 136(5):434-9. PubMed ID: 5662292 [No Abstract] [Full Text] [Related]
33. [Some notes on the principles of correct and reasonable topical dermatologic treatment]. Kalenský J Cesk Dermatol; 1975 Oct; 50(5):341-4. PubMed ID: 1192475 [No Abstract] [Full Text] [Related]
34. Excipients in topical corticosteroid preparations in Canada. Hogan DJ CMAJ; 1989 Nov; 141(10):1032. PubMed ID: 2804821 [No Abstract] [Full Text] [Related]
35. [Skin reactions to topical agents]. Bachy M Sem Hop; 1977 Feb; 53(8):493-6. PubMed ID: 190698 [TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid action on skin collagen: overview on clinical significance and consequences. Nuutinen P; Autio P; Hurskainen T; Oikarinen A J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):361-2. PubMed ID: 11730056 [No Abstract] [Full Text] [Related]
37. Potential ototoxicity from triamcinolone, neomycin, gramicidin and nystatin (Tri-Adcortyl) cream. Thomas SP; Buckland JR; Rhys-Williams SR J Laryngol Otol; 2005 Jan; 119(1):48-50. PubMed ID: 15807966 [TBL] [Abstract][Full Text] [Related]
38. [Side effects of dermatologic local therapy]. Haustein UF; Barth J Z Gesamte Inn Med; 1983 Dec; 38(24):663-8. PubMed ID: 6230803 [TBL] [Abstract][Full Text] [Related]
39. [Reducing the dosage by new technology]. Steinhorst M Hautarzt; 2001 Jan; 52(1):p following 90 (91). PubMed ID: 11220248 [No Abstract] [Full Text] [Related]
40. [Topical corticosteroids in dermatology--advantages and side effects]. Wojas-Pelc A; Setkowicz M; Bogdaszewska-Czabanowska J Przegl Lek; 2002; 59(3):170-4. PubMed ID: 12184032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]